Cargando…
Efficacy of Different Doses of Daprodustat for Anemic Non-dialysis Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
(1) Background: Anemia affects about 40% of patients with chronic kidney disease (CKD). Daprodustat improves serum hemoglobin in anemic patients by inhibiting prolyl hydroxylase of hypoxia-inducible factor. We conducted a network meta-analysis to investigate the direct and indirect effects of differ...
Autores principales: | Fadlalmola, Hammad, Al-Sayaghi, Khaled, Al-Hebshi, Abdulqader, Aljohani, Maher, Albalawi, Mohammed, Kashari, Ohoud, Alem, Alaa, Alrasheedy, Mariam, Balelah, Saud, Almuteri, Faten, Alyamani, Arwa, Alwasaidi, Turki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145143/ https://www.ncbi.nlm.nih.gov/pubmed/35628849 http://dx.doi.org/10.3390/jcm11102722 |
Ejemplares similares
-
COVID-19 in Saudi Patients With Sickle Cell Disease: A Retrospective Multi-Center Study
por: Kashari, Ohoud, et al.
Publicado: (2021) -
Vitamin B12 Deficiency Presenting With Microangiopathic Hemolytic Anemia
por: Osman, Haitham, et al.
Publicado: (2021) -
Multiple Autoimmune Syndrome With Alopecia Universalis and Immune Thrombocytopenic Purpura
por: Alwasaidi, Turki A, et al.
Publicado: (2021) -
Daprodustat: First Approval
por: Dhillon, Sohita
Publicado: (2020) -
A Novel Variant of Adenosine Deaminase 2 Deficiency Presented With Chronic Thrombocytopenia, Anemia, and Early-Onset Stroke
por: Al-Hebshi, Abdulqader, et al.
Publicado: (2021)